Literature DB >> 25145512

Breast cancer morbidity: questionnaire survey of patients on the long term effects of disease and adjuvant therapy.

Stefan Feiten1, Jan Dünnebacke2, Jochen Heymanns3, Hubert Köppler3, Jörg Thomalla3, Christoph van Roye3, Diana Wey2, Rudolf Weide3.   

Abstract

BACKGROUND: Many women have symptoms of various kinds after being treated for breast cancer. It is unclear how frequently these different side effects of treatment arise.
METHOD: All women who underwent surgery for breast cancer and subsequently received adjuvant systemic treatment in a single certified breast-cancer center from 2006 to 2010 were asked to fill out a standardized questionnaire. Medical data were retrieved from their charts and statistically analyzed together with the questionnaire responses. The questionnaire was also given to an age-adjusted control group.
RESULTS: 734 questionnaires were filled out and returned (response rate, 70%). The mean interval from the diagnosis of breast cancer to the time of response to the questionnaire was 38 months. The median age at time of response to the questionnaire was 65 years (range, 30 to 91 years). The distribution of UICC stages at the time of initial diagnosis was as follows: I 46%, II 42%, III 12%. 78% of the patients underwent breat conserving surgery, 85% had radio - therapy, 85% had antihormonal treatment, and 49% had chemotherapy. 91% were satisfied or very satisfied with the outcome of surgery. 34% reported operation site pain; 35% reported limitations of shoulder or arm function. Younger patients suffered from emotional sequelae more than older ones did. 25% reported a change in their relationship with their spouse. Before being diagnosed with breast cancer, 9% had consulted a psychiatrist or psychotherapist; after the diagnosis, 19% did. 14% had taken psychoactive medication before the diagnosis, and 26% did afterward.
CONCLUSION: Treatment for breast cancer has negative physical, emotional, and social effects on many patients. They suffer these effects to varying degrees depending on age, type of surgery, and systemic treatment.

Entities:  

Mesh:

Year:  2014        PMID: 25145512      PMCID: PMC4148709          DOI: 10.3238/arztebl.2014.0537

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  34 in total

Review 1.  Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer.

Authors:  A H Partridge; H J Burstein; E P Winer
Journal:  J Natl Cancer Inst Monogr       Date:  2001

Review 2.  Psychosocial and sexual functioning of survivors of breast cancer.

Authors:  Alice B Kornblith; Jennifer Ligibel
Journal:  Semin Oncol       Date:  2003-12       Impact factor: 4.929

Review 3.  Neuropsychological functioning following systemic treatment in women treated for breast cancer: a review.

Authors:  R Morse; J Rodgers; M Verrill; K Kendell
Journal:  Eur J Cancer       Date:  2003-11       Impact factor: 9.162

Review 4.  What is the effect of systemic anticancer treatment on cognitive function?

Authors:  Alessandro Minisini; Gul Atalay; Andrew Bottomley; Fabio Puglisi; Martine Piccart; Laura Biganzoli
Journal:  Lancet Oncol       Date:  2004-05       Impact factor: 41.316

5.  G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences.

Authors:  Franz Faul; Edgar Erdfelder; Albert-Georg Lang; Axel Buchner
Journal:  Behav Res Methods       Date:  2007-05

6.  Cognitive function in breast cancer patients receiving adjuvant chemotherapy.

Authors:  C B Brezden; K A Phillips; M Abdolell; T Bunston; I F Tannock
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

Review 7.  Breast cancer chemotherapy-related cognitive dysfunction.

Authors:  Tim A Ahles; Andrew J Saykin
Journal:  Clin Breast Cancer       Date:  2002-12       Impact factor: 3.225

Review 8.  Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis.

Authors:  Alex J Mitchell; David W Ferguson; John Gill; Jim Paul; Paul Symonds
Journal:  Lancet Oncol       Date:  2013-06-05       Impact factor: 41.316

9.  Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.

Authors:  Nadine Tchen; Helen G Juffs; Fiona P Downie; Qi-Long Yi; Hanxian Hu; Irene Chemerynsky; Mark Clemons; Michael Crump; Paul E Goss; David Warr; Mary E Tweedale; Ian F Tannock
Journal:  J Clin Oncol       Date:  2003-11-15       Impact factor: 44.544

Review 10.  Cardiotoxicity and oncological treatments.

Authors:  Axel Schlitt; Karin Jordan; Dirk Vordermark; Jürgen Schwamborn; Thorsten Langer; Christoph Thomssen
Journal:  Dtsch Arztebl Int       Date:  2014-03-07       Impact factor: 5.594

View more
  13 in total

1.  Positive psychological effects.

Authors:  Vincenzo Penna; Nestor Torio-Padron; G Björn Stark
Journal:  Dtsch Arztebl Int       Date:  2015-03-06       Impact factor: 5.594

2.  In reply.

Authors:  Stefan Feiten; Jan Dünnebacke; Rudolf Weide
Journal:  Dtsch Arztebl Int       Date:  2015-03-06       Impact factor: 5.594

3.  Different procedures should be on offer.

Authors:  Jochen-Frederick Hernekamp; Thomas Kremer; Ulrich Kneser; Jörg Heil; Christof Sohn
Journal:  Dtsch Arztebl Int       Date:  2015-03-06       Impact factor: 5.594

4.  Effect of an Internet-based telehealth system on functional capacity and cognition in breast cancer survivors: a secondary analysis of a randomized controlled trial.

Authors:  Noelia Galiano-Castillo; Manuel Arroyo-Morales; Mario Lozano-Lozano; Carolina Fernández-Lao; Lydia Martín-Martín; Rosario Del-Moral-Ávila; Irene Cantarero-Villanueva
Journal:  Support Care Cancer       Date:  2017-06-22       Impact factor: 3.603

5.  Lymphedema, musculoskeletal events and arm function in older patients receiving adjuvant chemotherapy for breast cancer (Alliance A171302).

Authors:  Judith O Hopkins; Jake Allred; Arti Hurria; Aminah Jatoi; Jacqueline M Lafky; Harvey Cohen; Clifford Hudis; Eric Winer; Jeanne Mandelblatt; Ann Partridge; Lisa Carey; Hyman B Muss
Journal:  Breast Cancer Res Treat       Date:  2017-08-20       Impact factor: 4.872

6.  Follow-up Reality for Breast Cancer Patients - Standardised Survey of Patients and Physicians and Analysis of Treatment Data.

Authors:  S Feiten; J Dünnebacke; V Friesenhahn; J Heymanns; H Köppler; R Meister; J Thomalla; C van Roye; D Wey; R Weide
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-05       Impact factor: 2.915

7.  Sex-determining Region Y-box transcription factor 13 promotes breast cancer cell proliferation and glycolysis by activating the tripartite motif containing 11-mediated Wnt/β-catenin signaling pathway.

Authors:  Xiaoyan Jin; Xuan Shao; Wenyang Pang; Zhengyi Wang; Jian Huang
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 8.  The potential role of angiogenesis in the development of shoulder pain, shoulder dysfunction, and lymphedema after breast cancer treatment.

Authors:  Trevor S Mafu; Alison V September; Delva Shamley
Journal:  Cancer Manag Res       Date:  2018-01-15       Impact factor: 3.989

Review 9.  Adipose regeneration and implications for breast reconstruction: update and the future.

Authors:  Emman J Combellack; Zita M Jessop; Naghmeh Naderi; Michelle Griffin; Thomas Dobbs; Amel Ibrahim; Stephen Evans; Stephanie Burnell; Shareen H Doak; Iain S Whitaker
Journal:  Gland Surg       Date:  2016-04

10.  The Sister Study Cohort: Baseline Methods and Participant Characteristics.

Authors:  Dale P Sandler; M Elizabeth Hodgson; Sandra L Deming-Halverson; Paula S Juras; Aimee A D'Aloisio; Lourdes M Suarez; Cynthia A Kleeberger; David L Shore; Lisa A DeRoo; Jack A Taylor; Clarice R Weinberg
Journal:  Environ Health Perspect       Date:  2017-12-20       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.